How
TheMedTechindustryisdynamicandrapidly evolving,requiringleaderswhocanadaptto changeandnavigatechallengeswithresilience. Influentialleaderspossesstheabilitytoembracenew technologies,pivotstrategieswhenneeded,andpersevere throughsetbacks.Theyareagileandcontinuouslyseek opportunitiesforlearningandgrowth.
MedTechleadershaveadeepunderstandingofmedical technologies,scientificprinciples,andhealthcaresystems. Theypossessexpertiseinareassuchasbiotechnology, medicaldevices,digitalhealth,diagnostics,and pharmaceuticals.Thistechnicalknowledgeallowsthemto driveinnovation,makeinformeddecisions,andguidetheir organizationstowardsdevelopingcutting-edgesolutions.
SuccessfulleadersinMedTechhaveaclearstrategicvision fortheirorganizationsandtheindustryasawhole.They possesstheabilitytoanticipatefuturetrends,identify emergingopportunities,anddefinearoadmapforgrowth andsuccess.Theycantranslatetheirvisionintoactionable strategiesandeffectivelycommunicateittotheirteams, stakeholders,andinvestors.
Inadditiontotechnicalexpertise,influentialleadersin MedTechhaveasolidgraspofbusinessprinciplesand marketdynamics.Theyunderstandthefinancialaspectsof runningasuccessfulMedTechcompany,including fundraising,budgeting,andrevenuegeneration.Theycan identifymarketopportunities,developviablebusiness models,andforgestrategicpartnershipsandcollaborations.
InfluentialleadersinMedTechhaveavisionarymindset. Theycanenvisionthefutureofhealthcareandunderstand
thepotentialoftechnologytotransformpatientcare.They haveaclearvisionfortheirorganizationsandtheindustry asawhole,andtheyinspireotherswiththeirforwardthinkingideasandinnovativeapproaches.
LeadersinMedTechrecognizetheimportanceof continuouslearningandpersonalgrowth.Theystay updatedonthelatestadvancements,scientificresearch,and industrytrends.Theyinvestintheirownprofessional developmentandencourageacultureoflearningwithin theirorganizations.Theyareopentonewideas,feedback, andinnovation,constantlyseekingopportunitiestoimprove themselvesandtheirteams.
FeaturingtheenthrallingstoriesoftheleadersinMedTech whoaredrivingeternalbettermentsinthemodern healthcaresector,InsightsSuccess—throughitslatest edition—shedslightonThe10MostInfluentialLeaders inMedTech-2023
Flip through the pages and Have a Delightful Read!
AbhhekJoi
Editor-in-Chief
Merry D'Souza
Deputy Editor Executive Editor Assistant Editors
Abhishek Joshi
Revati Badkas
Senior Sales Manager
Business Development Manager
Marketing Manager
Visualizer David King Art & Design Director Associate Designer Sihanee M., Rouniyar A. Peter Collins John Matthew
Technical Head Technical Specialist
Sales Executives
Patrick James
Business Development Executives Steve, Joe Jacob Smile Prachi Mokashi Dominique T.
Digital Marketing Manager
Research Analyst
Database Management Technology Consultant
March, 2023
Ankita Pandharpure Follow us on : www.facebook.com/insightssuccess/ www.twitter.com/insightssuccess We are also available on :
FeaturedPerson
AlbertoCondeMellado Ph.D
IndustrialEngineer NutritionSciences
BassilAkra CEO
BhaskarSambasivan SeniorAdvisor
BjörnAlbrecht Partner
DeanErhardt President&CEO
JacquelineAnim Sr.PrincipalMaterials Engineer
KerenLeshem CEO
LisaSasso President&Executive CoachorExecutive CareerCoach
PratapSarker CEO
Brief CompanyName
GlucoVibes glucovibes.com
AKRATEAMGmbH akrateam.com
CitiusTech citiustech.com
Albertoholdsmorethan15yearsworkingwithdataand improvingbusinessprofitability
BassilissupportingMedicalDeviceandIn-VitroDiagnostic Industrytogetsafe,qualitativeandwell-performingproducts inthemarket.
BhaskarSambasivanhasbeenintheHealthcareandLife Sciencesservicesindustryforabout30yearsandhasserved manyclientsinleadershiproles,establishingstrategic partnershipstohelptransformtheirbusiness.
Björn’sworkcoversthewholevaluechainfromearly discoverystrategiesthroughclinicaldevelopmentto commercializationandreimbursementforcancermedicines. McKinsey mckinsey.com
D2Solutions d2rx.com
Ethicon(Johnson&Johnson) jnjmedtech.com
OCONHealthcare oconmed.com
MedicalDevelopment Partners meddevpartners.com
GreenwayHealth greenwayhealth.com
TinaRaine-Bennett CEO
Medicines360 medicines360.org
Deanoffersover30yearsofstrategicmarketingand managementexperienceacrossboththeconsumerproductand pharmaceuticalarenas.
Jacquelinehasover25yearsofmaterialsandprocess technologysolutionsexperienceforplasticapplicationsin automotiveandmedicaltechnologyenvironment.
Kerenisaseasonedexecutivewithover20years’experiencein themedicaldevice&pharmaceuticalindustriesspecializingin themanagementofinnovativestart-ups,strategy, commercialization,BDandfinancing.
Lisaempowersaspiringleadersandexecutivesinthemedical deviceandlifesciencesfieldsonsettingandachievingboth personalandprofessionalgoals,maintainingwork/lifebalance andultimatelyreachingtheirgreatestpotential.
Pratapisaninnovativeandhighenergyleaderwithasuccessful trackrecordofdeveloping,leadingandgrowingmulti-Billiondollarbusinessesacrossserviceofferingsandindustry segments.
Tinafocusesonexpandingresearchonwomen'shealthand translatingwomen'shealthresearchintoclinicalpracticewithin theObstetricsandGynecologydepartments
Dean Erhardt President & CEO D2 Solutions
I have been leading D2 Solutions through a transformation from a traditional consulting organization to a technology-driven organization delivering SaaS solutions to industry stakeholders.
Workingthewayuptosuccessrequiresinnovationasthecriterionintoday’sdigitalage. Technologicaltransformationsmustbethe drivingforceofeverybusinessinordertoscaleitsprogress.Ensuringthatthisaspectisnotneglectedinvarious healthcaresectorsisDeanErhardt.
Drivingthetransformationofstrategicmarketingand managementexperienceacrossboththepharmaceuticaland consumerproductarenasforover25years,Deanis currentlythePresidentandCEOofD2Solutions.His areasofexpertiseincludeanalysisanddevelopmentof pharmaceuticaldistribution,reimbursementandpatient supportprograms.FurtherunderhisleadershipD2has developedvariousSaaSsolutionsfocusedonhelping variousstakeholdera)driveadditionalrevenue,b)decrease operationalcostandc)reduceexposuretoregulatoryrisk.
Deanhasworkedwithover100pharmaceutical,biotech, andmedicaldevicemanufacturersassistinginthestrategic andtacticalexecutionoftheirmarketinitiatives.In addition,Mr.Erhardthasworkedwithnumeroussmalland midsizedpharmaceuticalandbiotechorganizationsinthe areasofstrategydevelopment,channelmanagement, productreimbursementandpatientservices.
Inaninterview, Insights Success hadacomprehensive discoursewithDeantounderstandhismodelofsolutionorientedservices.
Below are the highlights of the interview:
Brieflydescribeyourprofessionaljourneyupuntilnow.
PriortomyroleatD2,Iservedinrolesofincreasing responsibilitywithExpressScripts,CardinalHealth,and USHealthcare.MymostrecentcorporaterolewasVice PresidentofSalesandMarketingfortheExpressScripts SpecialtyPharmacyBenefitsManagementgroup.Inthis role,IworkedwithmultipleManagedCareandPayer organizations,developingformularies,reimbursement models,andproductsupportprogramsforspecialtyand biotechtherapeuticcategories.
Previously,IledSalesandMarketingforExpressScripts SpecialtyDistributionServices,workingwithover30 pharmaceuticalmanufacturersintheareasofLimited Distributionprograms,PatientAssistanceprograms, Sampling,ReimbursementSupport,andotherproductspecificsupportprograms.
Whatchallengesdidyoufacealongtheway?
Thequestionis,whatchallengeshavewenotfaced?The D2teamsworkhardtolistentoourclientsanddevelop solutionsthatsolvereal-worldproblems.Intoday’s environment,organizationsfacelimitedresourcesinthe areasoftime(toomuchtodowithlimitedpersonnel resources),talent(asignificantchallengeinfindingand retainingtalent),andmoney(limitedfinancialresources). Thesechallengesfacedbyourclientswerealsoconfronted byD2;atthesametime,wewereworkingtodevelop solutionsforourclientpartners.
Whatsignificantimpacthaveyoubroughttothe MedTechindustry?
IhavebeenleadingD2Solutionsthroughatransformation fromatraditionalconsultingfirmtoatechnology-driven organizationdeliveringSaaSsolutionstoindustrystakeholdersthatdriveoperationalefficienciesbyreducingthe needforhumanlabor,enablingbetterregulatorycompliance,andacceleratingrevenuecapture.IntodaysenvironmentwearenotfacedwiththequestionofifweWANTto domorewithless,butratherweareinasituationwherewe MUSTdomorewithless.
TellusaboutD2Solutionsanditsfoundationpillar.
D2empowershealthcareleaderswithauniquecombination ofSaaSsolutionsanddeepconsultingexpertise,focusing oneliminatingkeyfrictionpointsinthemarketplacetohelp healthcarestakeholdersachievebetterefficienciesandattain improvedpatientresults.
D2wasfoundedin2008andfocusedonprovidingservices intheareasofdistributionandreimbursement.In2015,D2 begantheprocessofincludingtechnology-basedsolutions.
D2 empowers healthcare leaders with a unique combination of SaaS solutions and deep consulting expertise, focusing on eliminating key friction points in the marketplace.
Today,D2hassuccessfullycombinedconsultingand technologytoprovideacombinationofstrategicconsulting, tacticalimplementation,andSaaStechnologysolutions. Onehundredpercent(100%)ofD2’sfocusisinthe healthcaresector,withclientsincludingPharmaand Biotechmanufacturers,SpecialtyPharmacies,Payers, HospitalSystems,andPBMs.D2’straditionalconsulting focusisintheareasofSupplyChainManagement,Market Access(Pricing&Reimbursement), PharmacyOperations andPatientServices.
D2hasdevelopedauniquesetofservicesincludingbutnot limitedtoSourcingManufacturingcapacity;Settingupthe completesupplychannel,includingallaspectsofPatient Support;MarketAccess,includingfullPayercoveragefor Commercial,Medicare,Medicaid,andVA/DoD;SaaS solutionstocapturepatientsattheMDofficeandaccelerate patientenrolmentintomanufacturerprogramsaswellasto administerelectronicBenefitVerificationforthe onboardingprocessalongwithtofacilitatedigitalcomplianceanddiseasemanagementofpatientsthroughtheirfull courseoftherapy
HowdoesD2Solutionspromoteworkforceflexibility, andwhatisyourroleinit?
D2hasalwaysbeenanat-homeworkenvironment.We worktoencourageemployeestobeengagedandto recognizethatalloftheircontributionsarehighlyvalued.
Whatisyourtakeontechnology’simportance,andhow areyouleveragingit?
Technologymustenhanceyourbusiness,notforceyouto revampbusiness–whichcreatesasignificantrisktoan organization.D2’stechnologyfocusesonworkflow efficiencyandeasy-to-incorporatesolutionsthathelp organizationstocapturemorerevenue,enhanceoperational margin,anddiminishexposuretopotentialbusinessrisk.
Thesepillarsenableorganizationstogetmoredonewith lesshumanlabor,allowingstakeholderstoaddressthe issuesoflaborshortageandever-increasinglaborcoststhat areplaguingallstakeholders.
Whatwillbethefollowingsignificantchangeinthe MedTechindustry,andhowareyoupreparingforit?
ThereareseveralmajorshiftsgoingonintheMedTech environment.
Ÿ Patientcarewillcontinuetoevolveatanever-increasing pace.FDA-approveddigitaltherapeutics,inadditionto everydaywearables,willenablePatientstobemore informedaboutallaspectsofhowtheirlifestyleimpacts theirhealthandhowtheirindividualdecisionscan impacttheiroverallhealth.
Ÿ Technologiesthatdrivemeasurableenhancementstoan organization(anareaoffocusforD2)–enabling changes,suchasa)organizationstoworkfaster,b) Patientstoprovidemorereal-timefeedbackontheir care,c)theabilitytoacceleratePatientonboardingto drugsandtherapies,andd)organizationstoscalewith lesshumanintervention,etc.Theseareallexamples whereMedTech–willenhancethedeliveryof healthcareforProviders,Patients,andPayers.
Whatareyourgoalsintheupcomingfuture?
D2issingularlyfocusedonaddressingworkflowefficiency thatcantakecostoutofthehealthcaredeliverymodelwhile creatinganextremelypositivepatientexperience.Continuedissuesinandarounddrugcosts,laborcost/labor shortages,administrativeburden,andworkerburnout, amongothers,mustbeaddressed–andcanonlybe addressedviatechnology.
Theseissuesputatrisktheabilityoforganizations,suchas pharmacies,hospitals,andclinics,toprovidehigh-quality caretoanincreasinglyelderlyUSpopulation.
Whatadvicewouldyouliketogivethenextgeneration ofaspiringbusinessleaders?
IwouldliketoadvisethemtoFocusontheoutcomeyou aretryingtoachieveandfightlikecrazytoachieveit.Don’t allowsetbackstotakeawayfromavisionthathashigh stakeholdervalue.
D2 is singularly focused on addressing workflow efficiency that can take cost out of the healthcare delivery model.
Womenleadershipisanimportantaspectof
empoweringwomeninvariousfieldsand promotinggenderequality.Womenleaders bringuniqueperspectives,experiences,andapproachesto leadership,whichcanleadtomorecreativeandeffective decision-making.Womenleadersalsoserveasrolemodels forthenextgenerationofwomenandgirls,inspiringthem topursuetheirownleadershippaths.
Inrecentyears,therehasbeenasignificantincreaseinthe numberofwomeninleadershippositionsacrossvarious sectors,includingpolitics,business,andnon-profit organizations.However,despitetheseadvances,women stillfacenumerouschallengesandbarrierswhenitcomes toattainingandmaintainingleadershiproles.Someofthese challengesincludethegenderpaygap,lackofmentorsand sponsors,andapersistentculturalbiasthatviewswomenas lesscompetentorlessqualifiedforleadershippositions.
Toovercomethesechallengesandpromotegenderequality inleadership,avarietyofinitiativeshavebeenlaunched, includingmentorshipprograms,leadershipdevelopment training,anddiversityandinclusioninitiativesinthe workplace.Theseinitiativesareaimedatcreatinga supportiveenvironmentforwomentothriveasleadersand removingthesystemicbarriersthatpreventwomenfrom advancingtoleadershippositions.
FundraisingisanimportantaspectofLeadershiprolesand importantforsecuringresourcesandsupportforvarious causes,includingwomen'shealth.Women'shealthisa broadfieldthatencompassesawiderangeofissues, includingreproductivehealth,maternalhealth,andgenderbasedviolence.Ensuringaccesstoqualityhealthcareand addressingthesehealthconcernsiscrucialfortheoverall well-beingofwomenandgirls.
Thereareavarietyofwaystoraisefundsforwomen's healthinitiatives,includingcrowdfundingcampaigns, fundraisingevents,andpartnershipswithcorporationsand foundations.Crowdfundingplatformsallowindividualsand organizationstoraisefundsforspecificprojectsorcauses, whilefundraisingeventssuchaswalks,runs,orgalascan raiseawarenessandfundsforwomen'shealthinitiatives.
Partnershipswithcorporationsandfoundationscanalso playasignificantroleinraisingfundsforwomen'shealth initiatives.Thesepartnershipsofteninvolvethedonationof funds,resources,orexpertisetosupportwomen'shealth initiatives.Somecorporationsalsohaveprogramsinplace tosupportthehealthandwell-beingoftheiremployeesand theirfamilies,includinginitiativesfocusedonmaternaland reproductivehealth.
Inconclusion,women'sleadershipandfundraisingfor women'shealtharebothcrucialcomponentsofpromoting genderequalityandimprovingthelivesofwomenand girls.Whileprogresshasbeenmadeinrecentyears,thereis stillmuchworktobedonetoaddressthechallengesand barriersthatwomenfaceintheseareas.
Throughcontinuedeffortstosupportandempowerwomen leadersandtosecureresourcesforwomen'shealth initiatives,wecanworktowardsafuturewherewomen haveequalopportunitiesandaccesstotheresourcesthey needtothrive.
Thefieldofmedicaltechnology(MedTech)is
experiencingrapidadvancementsdrivenby technologicalinnovations.Theseinnovationsare revolutionizinghealthcaredelivery,improvingpatient outcomes,andtransformingthewaymedicalprofessionals diagnose,treat,andmanagediseases.Thisarticleexplores someofthecutting-edgetechinnovationsthatareenabling significantadvancementsintheMedTechsector,ultimately enhancingthequalityofpatientcareandmedicalpractices.
AIandmachinelearningalgorithmsarerevolutionizing MedTechbyanalyzingvastamountsofmedicaldatato identifypatterns,predictoutcomes,andassistindecisionmaking.Thesetechnologiescanimprovediagnostic accuracy,enhancepatientmonitoring,andenable personalizedtreatmentplans.AI-poweredtools,suchas imagerecognitionsoftware,canassistradiologistsin detectingabnormalities,whilemachinelearningalgorithms canhelpidentifypotentialdruginteractionsoroptimize treatmentprotocols.
TheInternetofThings(IoT)istransforminghealthcare throughtheInternetofMedicalThings(IoMT).Connected medicaldevicesandwearablescollectreal-timepatient data,enablingremotemonitoring,earlydetectionofhealth issues,andtimelyinterventions.IoMTdevicesrangefrom fitnesstrackersandsmartwatchestoadvancedmedical implantsandbiosensors.Thesetechnologiesenhance preventivecare,enabletelemedicine,andimprovepatient engagementinmanagingtheirhealth.
Roboticsystemsandsurgicalautomationarereshaping surgicalprocedures,offeringenhancedprecision,efficiency, andsafety.Robot-assistedsurgeriesallowsurgeonsto performcomplexprocedureswithgreateraccuracy,smaller incisions,andreducedrecoverytimes.Surgeonscancontrol roboticarmsequippedwithadvancedimagingandsurgical tools,providingenhanceddexterityandvisualizationduring procedures.Surgicalautomationalsoincludesautonomous systemsthatassistwithtaskssuchasmedication dispensing,reducingerrorsandimprovingmedication management.
Virtualandaugmentedrealitytechnologiesarefinding applicationsinmedicaltraining,surgicalplanning,and patientcare.VRallowsmedicalstudentsandprofessionals tosimulatesurgeriesandpracticecomplexproceduresina virtualenvironment,enhancingtrainingeffectiveness.AR overlaysdigitalinformationontotherealworld,aiding surgeonswithreal-timeguidanceduringoperations. Additionally,VR/ARcanbeusedtoalleviatepatient anxiety,provideimmersivetherapyexperiences,and facilitateremoteconsultations.
Advancementsingenomics,fueledbynext-generation sequencingtechnologies,aretransformingthelandscapeof precisionmedicine.Genomicprofilingenablespersonalized treatmentplansbasedonanindividual'sgeneticmakeup, identifyinggeneticpredispositionstodiseasesandguiding targetedtherapies.Theavailabilityoflarge-scalegenomic databasescombinedwithAIalgorithmsallowsformore accuratediagnosesandtailoredtreatmentstrategies,leading toimprovedpatientoutcomes.
Telehealthsolutionsandremotemonitoringtechnologies havegainedsignificantprominence,particularlyinlightof theCOVID-19pandemic.Thesetechnologiesfacilitate virtualconsultations,remotepatientmonitoring,and telemedicineservices,enablingpatientstoreceivetimely carefromthecomfortoftheirhomes.Remotemonitoring devicestrackvitalsigns,medicationadherence,anddisease progression,allowinghealthcareproviderstointervene promptlyandoptimizetreatmentplans.
3Dprinting,oradditivemanufacturing,ismaking significantcontributionstoMedTechbyenablingthe productionofcustomizedmedicaldevices,prosthetics, implants,andanatomicalmodels.Thistechnologyallows forpreciseandpersonalizeddesign,enhancingpatient comfortandoptimizingtreatmentoutcomes.3Dprinting alsooffersthepotentialforon-demandmanufacturingof medicalsuppliesandequipment,addressingsupplychain challengesandimprovingaccessibilitytohealthcarein remoteareas.
BigDataAnalytics:
Theanalysisoflargeandcomplexhealthcaredatasetsis aidingmedicalprofessionalsingaininginsights,identifying trends,andmakinginformeddecisions.Bigdataanalytics canimprovediseasesurveillance,identifypopulationhealth patterns,andoptimizeresourceallocation.Italsoplaysa crucialroleinclinicalresearch,drugdevelopment,and personalizedmedicinebyanalyzingvastamountsof genomic,clinical,anddemographicdata.
BlockchainTechnology:
Blockchaintechnologyoffersenhancedsecurity, transparency,andinteroperabilityinhealthcaresystems.It canfacilitatesecuresharingofmedicalrecords,protect patientprivacy,andenableseamlessexchangeofhealth informationacrossdifferentproviders.Blockchain-based smartcontractscanautomateandstreamlineprocessessuch asinsuranceclaims,supplychainmanagement,andclinical trials,reducingadministrativeburdensandensuringdata integrity
Nanotechnology:
Nanotechnologyisrevolutionizingmedicalinterventions withitspotentialforprecisedrugdelivery,diagnostics,and tissueengineering.Nanoscaledevicesandparticlescan targetspecificcellsortissues,deliveringmedicationswith higherefficacyandfewersideeffects.Nanosensorsenable real-timemonitoringofbiomarkers,enhancingdisease detectionandmanagement.Additionally,nanomaterialsare beingusedintissueengineeringtodevelopartificialorgans andimplantablemedicaldevices.
Thereisanimplicittrustthathealthprofessionals,as
wellaspatientsandfamilies,placeinthemedical devicesandinstrumentstheyuse.Theyattachitto variousbodypartsofthepatientwiththeexpectationthat thematerialsusedinthemakingofthedevicewillnotbe harmfultothem.
Itiscriticalthatanyorallmaterialsaremedicallysafefor patientsordoctorstouse.ItwasJacquelineAnimwhowas thefirsttocointhephrase‘AllMaterialsarenotequal.’She calledupontheotherprofessionalsintheMedTechindustry tostartseparatingmedicalmaterialsfromnon-medical ones.
Animisasubjectmatterexpertwithmorethan28yearsof experienceintheindustry.Shecurrentlyholdstheposition ofSr.PrincipalMaterialsEngineeratEthicon,apartof Johnson&Johnson’sMedTechdivision Animisastrong operationprofessionalwhoishighlyskilledatcollaborating andleadingresearch&developmentteams.
Ethiconhas100yearsofhistoryofstandingalongwith healthcareprofessionalstoimproveandsavelives.Its surgicaltechnologiesandsolutionsincludesutures,staplers, energydevices,trocars,andhemostats,alongwith interventionalablation,robotics,anddigitalsolutions.
Inanexclusiveinterviewwith Insights Success,Jacqueline AnimgivesusaninsidelookattheMedTechindustryand shareshowsheisinfluencingchangethroughherexpertise. Below are the highlights of the interview:
Jacqueline,pleasedescribeforouraudienceyour professionaljourneyupuntilnow.
IstartedasaProcessEngineerintheMaterialsEngineering GroupatDelphiin1994.Overtheperiodofnext15years,I climbedtheladderattheorganizationwhileholdingseveral leadingpositionsontheway.In2009,Itookthepositionof SeniorExternalManufacturingEngineeratEthicon, Johnson&Johnson’sMedTechdivision.Ihaveworkedin variousdifferentdepartmentshere,fromExternal ManufacturingtoLifeCycletoR&D.Currently,Iamthe SeniorPrincipalMaterialsEngineerattheR&DMaterials department.
AfterobtainingmygraduateeducationinChemical Engineering,Ihadtheopportunitytojointheinterior divisionofGeneralMotorsthencalledInlandFisherGuide, whichlaterbecameDelphi.Whilethere,Inoticedthatwe haddatabasesfullofvalidatedmaterials(plastics,coatings, textiles,etc.).Thesematerialshadadesignated specification,suchasGMP.PC.001pre-approvedfor interiorcomponentmolding.
However,uponjoiningtheMedicalDeviceindustries,I quicklyrealizedtherewerenosuchsystems,which necessitatedtheurgentneedtoestablishamaterialdata managementsysteminMedTechatJNJ.Iamnowlooking toscaleitoutacrosstheentireindustry
Upon joining the MedTech division at JNJ I quickly realized the urgent need to establish a material data management system. I am now looking to scale it out across the entire industry.
Jacqueline Anim Sr. Principal Materials Engineer Ethicon (Johnson & Johnson)
Whatsignificantimpacthaveyoubroughttothe MedTechindustry?
IusedoneofthenumerousconferencesandMedTechtrade showeventstocallupontheindustrytosegregatemedical materialsfromnon-medicalalternatives.Ialsocoinedthe phrase “All Materials are not made equal” toemphasize thefactthatthereareindeedmaterialsthatarenotintended forpatientscontactingmedicaldevices.
Recently,IalsocreatedandledtheveryfirstnorthAmerica MedicalGradeConsortiumtodiscussaguidelinefor definingmedicalgradematerialsfortheentireMedTech industrywithovertwenty-fiveindustrycollaboratorsi.e., Trinseo,EMS,DuPont,Americhem,RTP,SHPP,Covestro, Nusil-Avantor,FosterCorporation,Avient,Celanese, Evonik,Invibio,Clariant,Victrex,Liveo,Solvay,Sabic, Moldex3D,justtomentionafew
TellusaboutJohnson&Johnsonanditsfoundation pillar.
ThefoundationpillarforJNJisOurCredo.AtJNJ,ourfirst responsibilityistothepatients,doctors,andnurses,to mothersandfatherswhouseourproductsandservice.In meetingtheirneeds,everythingwedomustbeofhigh quality.
WhatisthenextbigthinginMedTech?
Asyoumayknow,theMedTechspaceisacontinuum ecosystem.Technologiesthatareintendedforothermarkets arenowfindingtheirwayintomedicaldevicese.g.,with theintroductionofroboticanddigitalsurgery,therehas beenaninfluxofuseofcompositebraidedarticles,spun material,andinsulatingtapes.Craneandcableassembly materials,e.g.,non-SVHCareinhighdemand.Italmost seemslikethecustomcable/wiresolutionisinshort supply Theprocessofcustomizationrequiresextensive materialselection,suchascompliancetoUL94ratingsof V-2orbetteranddiversesterilizationtechniques.
Whatisyourtakeontechnology’simportance,andhow areyouleveragingit?
Technologyisinevitableastherearenowsystemsand infrastructurestosupportit,fore.g.,5G,cloudstorage,etc. enablesthemovementoflargedataatthespeedoflight.If
wehadareasoninthepasttoprocrastinate,thatlimitation hasbeenremoved.Inmyareaofinterest,it'sdifficultto drawafirewallbetweencollaboratorandcompetitionsince weallleveragefromthesamesources.Thus,unlessthe materialiscustomised,thematerialmanufacturerswill makeitavailabletootherOEMsinthesameclassification ofend-use.Thereisnotechnologysecretanywhereasthe high-volumesalehasafavourableinfluenceontheprice perpound.
WhatwillbethenextsignificantchangeintheMedTech industry,andhowareyoupreparingforit?
ThenextdisruptionchangeinMedTechismedicalmaterial segregationandstandardizationguidelinecompliancefor regulatedmaterialsuppliers.Thishasbeenagapanda significantindustryunmetneed,butweareworkingto closethisgap.Thisnewapproachwilltrickledowntoall thematerialdatabasesandlibrariestoenhanceintuitive segregationandselection.
Whatareyourgoalsintheupcomingfuture?
Myfocusisonthecollaboratingtoreleasetheuniversal medicalmaterialguidelineforshort-termpatientcontacting applicationsandpremedicalpackaging.
Whatadvicewouldyouliketogivethenextgeneration ofaspiringbusinessleaders?
Oneareathatisseekingforattentionisdesignforend-toendsustainability ThisisacalltotheMaterialsand MedTechindustrytoaddthispillarintheproductdesign processupfrontandnotafterthefact.
Pandemicandbiologychangedinjustoneyearmore
thantechnologyinthelast10years.Allthe technologicaltoolsweretherebutmostofallbig companieswerenotusingthemproperly.Andourlifestyle changedwithit.
Today,remoteworkingorteleworkingisverynormal,as areconferences,phonecallsandotheractivitiesthatleave behindthefacetofacenecessityandlotsoftravelingand commuting.
Thistendencyhasbecomethenewrealityanditcouldbea goodstepintheshorttermintermsofefficiencyand productivity,butithasacriticalimpactonthelifestyle habitsandemployees'health.Andthemainreasonisthat wedramaticallyreduceouractivityandwebecomemore sedentary.
Thissedentarylifestyleaffectshealthbadly,anditopensthe doortofuturemetabolismdisorderssuchasmetabolic syndrome,obesity,insomniaortype2diabetes.Wesaw fromGlucovibesusersthattheglucoselevelsofsedentary peopleishigheratallthetime,bothdayandnight.
Thismeansthattheinsulinlevelsarehigher,too,andthe lackofactivitytogetherwithahighdietincarbohydrates andsaturatedfatsistheperfectstormformetabolic disorders.
Activityisthemainregulatorofourglucoselevels,andit cannotbereplacedjustbyaspecificdietorcarbohydrates limitation.Ourbodyandmetabolismiscreatedtohavean
activeprofile,ourmusclesneedtobeusedtoavoidtheir atrophy.
Dietofcoursehasadirecteffectonglucoselevelsand metabolichealth,andmetabolicGPSlikeGlucovibes allowsyoutounderstandthiseffecttogetherwithactivity andresting,thethreemainpillarsofmetabolichealth.
Itisimportanttounderstandthatanyemployeeshould introduceinhis/herschedulesomeactivityeach90or120 minutes,alittlewalkof15or20minuteshaveapositive effectonthemetabolism,andifyoutakethisshortwalk afteryourmeals,ourbodyreceivethehelpofourmuscles toregulatetheintakeofenergyandglucoseofeachmeal.
Atthesametime,itisveryimportanttobalancethe nutrientsintake,inordertoavoidaplaincarbohydratemeal andmostofall,ahighaddedsugarmeal,whichisquite commoninalotofemployeesworkingremotelyto maintaintheirattention.Infact,highcarbohydrateintake mealsgeneratereactivehypoglycemiawhichmeansafocus depreciationandnewglucosedesireorcravingspushingus tokeepeatingallthetime.
Asimplewaytoregulatethemetabolismcouldbeabalance dietinProteins,CarbohydratesandhealthyFatstogether withfoodsrichinfiber,togetherwithsomeactivityevery day(a30minuteswalkingaftermealsismoreeffectivethat gotothegymtwiceaweek),with3to5intakesperday, and7to8hoursofgoodsleepwith10to14offasting periodfromdinnertobreakfast.Anearlydinnerhelps,and somestrengthworkoutasfirst"todo"inthemorning,even
Impactonglucoselevelsofeatingthesamechocolatepuffpastryduringawalkor inthesofa(byGlucovibes)
for10to15minutesregulatesourmetabolismfromthe beginningoftheday.Ofcourse,avoidingprocessedfoods andaddedsugarfoodsisagoodchoice.
Remoteworkingreducesactivityandcouldhavefatal consequencesinanymetabolismifwedonottakeaction andbalanceourlifestyle.Earlydeathandchronicmetabolic disordersaregrowingeachyearandthepandemicwill boostthesenumbersifwedonotunderstandhowtofaceit withbetterlifestylehabits.Fortunately,technologycould helphere,too,allowingusaguidanceormetabolicGPSas Glucovibesdoestounderstandthechangeandtheimpactof ourlifestyleonourhealth.
Theintersectionoftechnologyandhealthcarehasgivenrisetothe MedTechsector,whichplaysapivotalroleindrivingadvancements andtransformingtheglobalhealthcarelandscape.MedTech, encompassingmedicaldevices,digitalhealthsolutions,andtechnological innovations,isrevolutionizinghealthcaredelivery,improvingpatient outcomes,andenhancingoverallhealthcareefficiency.Thisarticleexplores howtheMedTechsectorisenablingsignificantadvancementsintheglobal healthcaresector,ultimatelybenefitingpatients,healthcareprofessionals,and healthcaresystems.
TheMedTechsectorhasintroducedinnovativediagnostictoolsandimaging technologiesthatenableearlierandmoreaccuratediseasedetection. Advancedmedicalimagingdevices,suchasMRI,CTscanners,and ultrasoundmachines,providedetailedandhigh-resolutionimages,aidingin thediagnosisofvariousconditions.Additionally,diagnosticdevicesand laboratorytechnologieshavebecomemoreportableandaccessible,enabling point-of-caretestingandfasterresults,therebyexpeditingtreatment initiation.
Digitalhealthsolutionsandwearabledevicesareempoweringpatientsto takecontroloftheirhealth.Mobilehealthapplications,patientportals,and telehealthplatformsprovideconvenientaccesstohealthcareservices,remote consultations,andhealthinformation.Wearabledevices,includingfitness trackersandsmartwatches,monitorvitalsigns,trackactivitylevels,and facilitateremotepatientmonitoring.Theseadvancementspromotepatient engagement,enableself-management,andfacilitatetimelyintervention.
TheMedTechsectorisenablingtheadvancementofpersonalizedmedicine, tailoringtreatmentplanstoindividualpatientsbasedontheirgenetic makeup,lifestyle,andspecifichealthcharacteristics.Genomics,proteomics,
andmoleculardiagnosticstechnologieshaveimprovedour understandingofdiseasesatamolecularlevel,allowingfor targetedtherapiesandprecisionmedicineapproaches.By analyzinglargedatasetsandemployingartificial intelligencealgorithms,healthcareproviderscanidentify biomarkers,predicttreatmentresponses,andoptimize medicationregimens.
MedTechinnovationsareaddressingthechallengeof healthcareaccess,particularlyinunderservedandremote areas.Telemedicineplatformsandmobilehealthsolutions enablevirtualconsultations,providingaccesstohealthcare professionalsregardlessofgeographicalconstraints. Remotemonitoringdevicesfacilitatethemanagementof chronicconditionsandallowhealthcareprovidersto remotelytrackpatienthealthparameters.Additionally, portablemedicaldevicesandmobileclinicsbring healthcareservicesdirectlytocommunities,enhancing accessibilityandreducinghealthcaredisparities.
SurgicaladvancementsfacilitatedbytheMedTechsector haverevolutionizedsurgicalprocedures,makingthemsafer, moreprecise,andminimallyinvasive.Robot-assisted surgerysystemsofferenhancedsurgicaldexterity,3D visualization,andpreciseinstrumentcontrol,enabling surgeonstoperformcomplexprocedureswithincreased precisionandreducedinvasiveness.Additionally,surgical navigationsystemsprovidereal-timeguidanceduring surgeries,improvingaccuracyandreducingcomplications.
MedTechsolutionsarestreamlininghealthcareoperations, improvingefficiency,andreducingadministrativeburdens. Electronichealthrecords(EHRs)andhealthinformation exchangesystemsenableseamlesssharingofpatient informationamonghealthcareproviders,enhancingcare coordinationandreducingduplicationoftests.Workflow managementsystemsautomateadministrativetasks, optimizeresourceallocation,andreducepaperwork, allowinghealthcareprofessionalstofocusmoreonpatient care.
TheMedTechsectorhasfacilitatedtheanalysisoflarge volumesofhealthcaredata,leadingtovaluableinsightsand
evidence-baseddecision-making.Advancedanalyticstools, includingartificialintelligenceandmachinelearning algorithms,cananalyzecomplexhealthcaredatasets, identifypatterns,andpredictoutcomes.Theseinsightsaid indiseasesurveillance,populationhealthmanagement,and treatmentoptimization,ultimatelyimprovinghealthcare deliveryandpatientoutcomes.
MedTechinnovationsareshiftinghealthcarefocustowards preventivecare.Connecteddevices,suchaswearable fitnesstrackersandsmarthomemonitoringsystems, encourageindividualstoadopthealthierlifestylesand engageinproactivehealthmanagement.
MedTechsolutionsenableremotemonitoringofpatients' vitalsigns,chronicconditions,andpost-surgicalrecovery Thiscapabilityallowshealthcareproviderstoremotely trackpatients'healthstatus,interveneinatimelymanner, andreducehospitalreadmissions.Telemedicineplatforms enablevirtualconsultations,connectingpatientswith healthcareprofessionalsfordiagnosis,treatment,and follow-upcare,regardlessofgeographicaldistance.
MedTechinnovationscontributetoenhancingpatientsafety withinhealthcaresettings.Technologiessuchasbarcode scanningsystemsandelectronicmedicationadministration records(eMARs)reducemedicationerrorsandimprove medicationmanagement.Smartinfusionpumpswithdose errorreductionsystemsandintegrateddruglibrariesensure accuratemedicationdelivery Additionally,technologies likeelectronichealthrecords(EHRs)provide comprehensivepatientinformation,reducingtheriskof adverseeventsandimprovingcarecoordination.
MedTechadvancementsfacilitateseamlessdata interoperabilityandintegrationamongdifferenthealthcare systemsanddevices.Thisenablestheexchangeofpatient information,testresults,andtreatmentplansbetween healthcareproviders,promotingcarecontinuityand avoidingredundanttests.Interoperabilityalsosupports populationhealthmanagement,researchcollaborations,and theintegrationofartificialintelligenceandanalyticstools fordata-driveninsights.
